Associated Press (AP)
In the event of any of these symptoms occurring, it is advised that the patient discontinue use immediately and seek medical attention
About the REIMAGINE program REIMAGINE is a phase 3 clinical development program with once-weekly subcutaneous CagriSema in type 2 diabetes
Supports blood flow, improves hair density, and nourishes the skin barrier
Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani M-R, Hosseini S-M-R, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi S-M-H, Moghadam M, Gharibi F, Mirshafiee O:, Akhondzadeh S: N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study